UTime Technology Signs ~$10M Smart Health Wearables Deal With Tumu Vertex; Tumu Vertex Has Placed An Initial Purchase Order For 50,000 Premium Smart Health Devices From UTime

UTime Limited (NASDAQ:WTO), a global technology company engaged in the design and development of mobile devices today announced a major commercial breakthrough. UTime's Hong Kong subsidiary, UTime Technology (HK) Company Limited, has officially signed a smart health device procurement agreement worth nearly $10 million USD with Tumu Vertex LLC, a Denver-based entity, marking a crucial step in UTime's strategic deployment in the North American medical-grade smart wearable market.

Under the signed Sales Agreement, Tumu Vertex LLC has placed an initial purchase order for 50,000 premium smart health devices from UTime, comprising:

• 25,000 units of the UT-168 BT Blood Pressure Watch and 25,000 units of the UR08 ECG Smart Ring.
  
  
  
   
• 25,000 units of the UT-368 4G Blood Pressure Watch and 25,000 units of the UR01 Smart Ring
  
  
  
   

We believe this collaboration represents not only a breakthrough in volume but also brings us to a new level in technological integration. UTime's solution perfectly combines FDA-certified medical-grade monitoring technology with everyday wearable scenarios, representing the latest development trend in the smart health industry. The agreement follows internationally recognized trade frameworks, covering FOB Hong Kong delivery, phased payments, and standardized quality assurance systems.